An update on pathogenesis and management of tuberculosis with special reference to drug resistance

Journal Title: Asian Pacific Journal of Tropical Disease - Year 2015, Vol 5, Issue 9

Abstract

Drug resistance in tuberculosis (TB) is a global problem and both developed as well as under developed parts of the world are predisposed to drug resistant TB. Multiple drug resistant–TB (MDR-TB) designates the very strain of the pathogen which is resistant to at least two primary anti-TB drugs isoniazid and rifampicin. This strain after acquiring a further bacillary resistance to any second line injectable drug and any of the fluoroquinolones is termed as extensively drug resistant TB (XDR-TB). The present review is endeavored to recapitulate the contemporary state of multidrug resistance in TB, the pathophysiology and recent developments for a rapid and reliable detection of the infection and management of MDR-TB. The challenge of MDR-TB management must be embarked on by skilled doctors at operational BCL-3 laboratory facilities where all allied services for the in-vitro sensitivity testing of mycobacteria are available because it includes extended treatment with costly second–line drugs containing meticulous toxicity. Even more dreaded are some newly emerging TB strains namely XDR-TB which is resistant to many more anti-TB agents (such as isonicotinic acid hydrazide and rifampicin plus second line injectable streptomycin, amikacin and kanamycin). Newer discovery of novel anti-TB drugs through recent research regarding the management of drug resistant tuberculosis would help avert and eradicate MDR-TB as well as XDR-TB. For shortening of the TB–treatment regimen, a few drugs, especially gatifloxacin and moxifloxacin, are being tested, while PA-824, OPC-67683 and TMC-207 are also being studied for both drug resistant and drug susceptible disease. Given the past global trends in MDR-TB, if aggressive preventive and management strategies are not implemented against it, XDR-TB would emerge to a larger extent which would severely cripple global control efforts of TB. However, very recently a newly discovered drug bedoquinoline is demonstrating strong promise towards containment of XDR-TB.

Authors and Affiliations

Keywords

Related Articles

Comparison of effect of nicotine and levamisole and ivermectin on mortality of leech

Objective: To study the effect of different doses of nicotine on Limnatis in comparison with levamisole and ivermectin. Methods: In this interventional experimental study in July 2012, the amount of 61 mature leeches of...

Identification of mycobacteria and other acid fast organisms associated with pulmonary disease

Objective: To identify Mycobacterium tuberculosis (M. tuberculosis) and other acid fast organisms isolated from sputum of HIV positive adult patients with pulmonary disease in Jos, Nigeria. Methods: Acid fast organisms i...

Antibacterial and antioxidant activities of Vaccinium corymbosum L. leaf extract

Objective: To investigate antibacterial and antioxidant activity of the leaf extract of tropical medicinal herb and food plant Vaccinium corymbosum L. (V. corymbosum) . Methods: Free radical scavenging activity on DPPH,...

Computational drug discovery of potential phosphodiesterase inhibitors using in silico studies

Objective: To evaluate the phosphodiesterase inhibitory activity of flavonoids using in silico docking studies. Methods: In this perspective, flavonoids like Aromadedrin, Biochanin, Eriodictyol, Isorhamnetin, and Okanin...

Fungal contamination of produced wheat flour in West Azerbaijan, northwest of Iran

Objective: To investigate fungal contamination of produced wheat flours in West Azarbaijan Province, located in the North West of Iran as wheat flour is one of the most important food and nutrient in the Iranians diet. M...

Download PDF file
  • EP ID EP228138
  • DOI 10.1016/S2222-1808(15)60912-4
  • Views 66
  • Downloads 0

How To Cite

(2015). An update on pathogenesis and management of tuberculosis with special reference to drug resistance. Asian Pacific Journal of Tropical Disease, 5(9), 673-686. https://europub.co.uk/articles/-A-228138